Article Watch: September 2017

Journal Watch (Spring 2017)

Antibodies to watch in 2017

Over 50 investigational monoclonal antibody (mAb) therapeutics are currently undergoing evaluation in late-stage clinical studies, which is expected to drive a trend toward first marketing approvals of at least 6-9 mAbs per year in the near-term. In the United States (US), a total of 6 and 9 mAbs were granted first approvals during 2014 and 2015, respectively; all these products are also approv...

Vet September 2017.indd

Background: BVD and IBR are contagious viral diseases highly prevalent in Irish cattle. Despite their significant reproductive and economic impact very little is known about the BVD and IBR status of stock bulls (a bull used for breeding purposes). There are still a high proportion of dairy farms in Ireland that rely on the use of a bull for breeding cattle and ensuring the fertility of the bul...

Editorial, Issue: September 2017

Vet September 2017.indd

As many European countries are currently engaged in infectious bovine rhinotracheitis (IBR) control programmes, it is widely believed that an Irish IBR eradication scheme will be realised in the very near future. In fact, a growing movement across the EU to eradicate IBR could be a barrier to trade for Irish livestock as, under EU legislation, Member States who have compulsory disease eradicati...